Volume 30, Issue 175, September 2026 (Forthcoming Issue)

About the Cover

Alzheimer's disease is the most common form of dementia in the world, affecting tens of millions of people. Neuroinflammation is now known to be an important part of the process of Alzheimer's disease (AD) developing. In the past, it was thought of as a secondary byproduct of amyloid-beta (Aβ) plaque and tau neurofibrillary tangle accumulation, but it is now understood to be a central and early-acting pathological mechanism in AD progression. This review looks at how the brain and nervous system are affected by inflammation.

Previous

REVIEW

Neuroinflammation in Alzheimer's disease: current evidence and therapeutic targets - Part II

Izabela Ślusarczyk, Szymon Uszak, Adrianna Chachuła, Natalia Kruk, Jan Olszewski, Julia Rojek, Wojciech Szlajss, Patrycja Jędrzejewska, Tomasz Szczawiński, Daria Wieczorek

Alzheimer's disease is the most common form of dementia in the world, affecting tens of millions of people. Neuroinflammation is now known to be an important part of the process of Alzheimer's disease

Medical Science, 2026, 30, e180ms3904

Abstract | PDF

Clinical applications of platelet-rich fibrin (PRF) in dentistry and oral surgery: A review of the literature

Daria Wieczorek, Adrianna Chachuła, Natalia Kruk, Izabela Ślusarczyk, Jan Olszewski, Julia Rojek, Patrycja Jędrzejewska, Szymon Uszak, Wojciech Szlajss, Tomasz Szczawiński

Platelet-rich fibrin (PRF) is a biomaterial obtained from patients themselves. That made it an essential material in oral and maxillofacial surgery due to its effectiveness in stimulating tissue repair

Medical Science, 2026, 30, e181ms3915

Abstract | PDF